Search
What is being done for patient safety by different stakeholder
InSensitive Content: the impact on dermatologists
Learn about the importance of the dermatology community sharing content related to generalized pustular psoriasis on social media.
InSensitive Content: impact on the GPP patient community
Understand why the patient community should be able to post and consume visual content related to generalized pustular psoriasis.
Lendormin®
Short-term treatment of disorders of initiating and maintaining sleep. Insomnia requiring pharmacological intervention.
FRONTLINE
indicated for the treatment and prevention of fleas, ticks and chewing lice in dogs and cats, and aids in the control of sarcoptic mange in dogs.
Rabisin® / Raboral V-RG®
Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.
ProZinc
Protamine Zinc
Eqvalan® / Zimecterin® / Eqvalan®GoldEqvalan®Duo / Zimecteri
For treatment and prevention of parasitic infestations in horses and donkeys due to large and small strongyles, ascarids.
Broadline®
Protects cats against the broadest spectrum of internal and external parasites including adult fleas, flea eggs, flea larvae, ticks, heartworms, hookworms, roundworms, and tapeworms.
Vetmedin®
Treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation).
Praxbind®
Praxbind® is a specific reversal agent for dabigatran and is indicated in adult patients treated with Pradaxa® (dabigatran etexilate) when rapid reversal of its anticoaculant effects is required: for emergency surgery/urgent procedures; in life-threa
Rabisin® / Imrab®
Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.
What are acute exacerbations in IPF?
Risk factors for acute exacerbations in IPF are unclear, but there is evidence that a number of factors may increase risk. Learn more here.
HER2 TKI, Zongertinib
HER2 TKI, Zongertinib
BI 764198: TRPC6 inhibitor
BI 764198: TRPC6 inhibitor
786214027-001_BI_Speso_NS_Infographic_Overview_2024_cc04.pdf
TRPC6 inhibitor
PDE4B inhibitor
KISIMA® cancer vaccine
GlyT1 inhibitor
CatC inhibitor
Oxidase Inhibitor
Retinal Health
Human Pharma Clinical Pipeline Retinal Health therapeutic area